Sentences with phrase «for gynecologic cancers»
Our clinical trials for gynecologic cancers offer patients access to cutting - edge therapies that may not be available anywhere else.
http://www.hollingscancercenter.org/ Not exact matches
GYN Cancer Support Group - For patients who are diagnosed with a gynecologic cCancer Support Group - For patients who are diagnosed with a gynecologic cancercancer.
«Although FDA approval is critically important for introducing a new screening test or algorithm, providers ultimately rely on guidance or guidelines to help them make the best decisions for their patients and want to understand advantages, disadvantages and unknowns associated with a new screening approach,» said Huh, who is a senior scientist for the UAB Comprehensive Cancer Center, Director of the UAB Division of Gynecologic Oncology, and is also a board member for both the American Society for Colposcopy and Cervical Pathology and the Society of Gynecologic Oncology.
Today's guidance, written by a group of cervical cancer screening experts led by University of Alabama at Birmingham gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance.&cancer screening experts led by University of Alabama at Birmingham gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidagynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical GuidaGynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance.&Cancer Screening: Interim Clinical Guidance.»
«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.
In the Phase II clinical trial, Dr. Miller and colleagues in the National Cancer Institute - supported Gynecologic Oncology Group found that in patients who had not received prior chemotherapy, the combination cocktail had a 31 percent response rate for up to 7 months, and an overall survival of 12 months.
«We found that pemetrexed combined with cisplatin is less toxic, well tolerated, and should be developed for further treatment of cervical cancer,» said gynecologic oncology specialist Dr. David Miller, Professor of Obstetrics and Gynecology and a member of the Harold C. Simmons Cancer Ccancer,» said gynecologic oncology specialist Dr. David Miller, Professor of Obstetrics and Gynecology and a member of the Harold C. Simmons Cancer CCancer Center.
ACP found that the diagnostic accuracy of the pelvic examination for detecting gynecologic cancer or infections is low.
More than one - third of counties in the Unites States are located more than 50 miles from the nearest gynecologic oncologist, making access to specialty care for ovarian and other gynecologic cancers difficult for nearly 15 million women.
«This is the first national study to identify specific regions of the United States where residents may be at an increased risk for poor clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author ongynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author onGynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the study.
This study, conducted by the Gynecologic Oncology Group, a cooperative group funded by the National Cancer Institute, was the second to test bevacizumab under these conditions (first chemotherapy for platinum - sensitive recurrence), a use for which bevacizumab is not currently approved by the Food and Drug Administration.
Ovarian cancer accounts for 5 percent of cancer deaths among women, and causes more deaths than any other gynecologic cancer.
For women with ovarian cancer, a particularly deadly form of gynecologic cancer, even improvements in treatment outcomes have been elusive.
«Unfortunately, due to the lack of screening mechanisms for many gynecologic cancers, they are often diagnosed in an advanced stage, thus leading to poor treatment response with standard therapies in many cases.
Based on these results, two phase 3 trials are being planned for platinum - sensitive and platinum - resistant ovarian cancer patients by one of NCI's new National Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group cancer patients by one of NCI's new National Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG).
Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and the co-Leader of the Tumor Immunology and Immunotherapy research program.
For most women who have these gynecologic cancers, surgery is an important part of the initial treatment and increases the possibility of long - term success.
Brian M. Slomovitz, M.D., co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center, received the 2018 Presidential Abstract Award from the Society for Gynecologic Oncology on March 24 during the group's Annual Meeting on Women's Cancer in New Orleans.
«Based on a better understanding of its origins, our study suggests new strategies for the prevention and early detection of ovarian cancer,» senior study author Douglas A. Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center and professor of obstetrics and gynecology at NYU School of Medicine, tells Medcancer,» senior study author Douglas A. Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center and professor of obstetrics and gynecology at NYU School of Medicine, tells MedCancer Center and professor of obstetrics and gynecology at NYU School of Medicine, tells Medscape.
To learn more about current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients, watch Dr. Odunsi's webinar from June 4, 2013.
Both Carpen and Soto were referred to Ghadir Salame, MD, a member of NYU's Perlmutter Cancer Center who has earned a well - regarded reputation among obstetric and gynecologic colleagues in the New York metro region for his expertise in treating endometrial cancer using robot - assisted suCancer Center who has earned a well - regarded reputation among obstetric and gynecologic colleagues in the New York metro region for his expertise in treating endometrial cancer using robot - assisted sucancer using robot - assisted surgery.
Anxiety Disorders Arthritis Breast Cancer Cancer Risk Clinic Delayed Puberty Depression Digestive Diseases Eating Disorders Endometriosis Family Planning Gynecologic Conditions Gynecologic Cancers Headaches Heart Disease Incompetent Cervix Incontinence Infertility Lupus Menopause Menstrual Abnormalities Minimally Invasive Gynecologic Surgery Mixed Connective Tissue Disease Multiple Sclerosis Osteoporosis Pelvic and Vulvar Pain Pelvic Floor Defects Personalized Health & Prevention Plastic Surgery Polycystic Ovary Syndrome (PCOS) Pregnancy Scleroderma Sexual Health for Female Cancer Patients and Survivors Sexually Transmitted Diseases Skin Problems Thyroid Problems Urinary Incontinence Uterine Fibroids Varicose Veins Weight Loss Surgery Weight Management
Viswanathan, considered the preeminent expert in gynecologic radiation therapies, developed MRI - guided brachytherapy for cervical cancer and other gynecologic cancers.
Learn about your options for breast, gynecologic and colon cancer screening at Women & Infants Hospital.
The results of this study demonstrate a large, unmet need for attention to the sexual concerns of women who survive gynecologic and breast cancers.
Minimally invasive and robotic surgery is now used for treatment of a majority of women with gynecologic cancer.
The Gynecologic Cancer Program provides complete and compassionate care for women with gynecologic cancers including ovarian, uterine, cervical, vulvar, peritoneal, and fallopian tube cancers, as well as gestational trophoblastGynecologic Cancer Program provides complete and compassionate care for women with gynecologic cancers including ovarian, uterine, cervical, vulvar, peritoneal, and fallopian tube cancers, as well as gestational trophoblastgynecologic cancers including ovarian, uterine, cervical, vulvar, peritoneal, and fallopian tube cancers, as well as gestational trophoblastic disease.
It clearly shows that those who had maintenance [Avastin] had improved profession - free survival,» said Dr. Robert Morgan, co-director of the gynecologic oncology program at City of Hope Cancer Center in Duarte, Calif. «I think we have to wait for longer term outcomes before we make definite conclusions.
She beat the disease and is now working with the Gynecologic Cancer Foundation to educate women about human papillomavirus (HPV)-- a group of viruses that cause the vast majority of cervical cancer cases — and the importance of regular Pap tests to screen for cervical cCancer Foundation to educate women about human papillomavirus (HPV)-- a group of viruses that cause the vast majority of cervical cancer cases — and the importance of regular Pap tests to screen for cervical ccancer cases — and the importance of regular Pap tests to screen for cervical cancercancer.
In an interdisciplinary collaboration, the University of Pennsylvania School of Veterinary Medicine's Working Dog Center (photo above courtesy of University of Pennsylvania), the School of Arts and Science's Department of Physics and Astronomy, Penn Medicine's Division of Gynecologic Oncology, and the Monell Chemical Senses Center have joined together for a research investigation using canine olfaction, along with chemical and nanotechnology analysis, to detect early - stage human ovarian cancer.
Performed diagnostic cytopathology, processing gynecologic and non-gynecologic samples for cancer diagnosis.
About Youtuber For more than 30 years, OHC medical, radiation and gynecologic oncology specialists have been treating nearly every form of cancer and complex blood disorders.
About Youtuber The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologGynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologicgynecologic cancers.